LIED researchers together with Allmiral discover novel therapeutic target in EBA

Results published in Frontiers in Immunology:

Therapeutic effect of a novel PI3Kδ inhibitor in experimental epidermolysis bullosa acquisita

Front. Immunol. | doi: 10.3389/fimmu.2018.01558

This article is part of the Research Topic "Autoantibodies"

Mittwoch, 04.07.2018 22:21